Association between single nucleotide polymorphisms of DNA repair genes (BRCA1, BRCA2, and PALB2) and breast cancer incidence in a subset of Iranian population

被引:0
|
作者
Jahangiri, Sepideh [1 ]
Abdan, Zahra [1 ]
Houshmand, Massoud [2 ]
Souroush, Ali [3 ]
Aznab, Mozaffar [1 ,4 ]
机构
[1] Kermanshah Univ Med Sci, Clin Res Dev Ctr, Imam Reza Hosp, Kermanshah, Iran
[2] Natl Inst Genet & Biotechnol, Dept Med Genet, Tehran, Iran
[3] Kermanshah Univ Med Sci, Dept Med Phys, Kermanshah, Iran
[4] Kermanshah Univ Med Sci, Internal Med Dept, Med Oncol Hematol, Kermanshah, Iran
关键词
Breast cancer; BRCA1; BRCA2; PALB2; Polymorphism; TURKISH POPULATION; MUTATIONS; SUSCEPTIBILITY; RISK;
D O I
10.1186/s13053-025-00311-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundBreast cancer (BC) is the most common malignancy among Iranian females, accounting for 24.4% of all malignancies. Germ line mutations in DNA repair system-related genes are associated with an increased risk of BC. This study aims to evaluate the frequencies of single nucleotide polymorphisms (SNPs) in the BRCA1, BRCA2, and PALB2 genes in patients with BC from a subset of the Iranian population in the western part of Iran.MethodsBlood samples were collected from 335 patients with BC and 354 healthy matched volunteers. Genomic DNA was extracted using the salting-out method and, after quality control, was genotyped using the multiplex TaqMan allelic discrimination assay for three SNPs: rs80359550 (6174 delT) in the BRCA2 gene, rs180177102 in the PALB2 gene, and rs386833395 (185delAG) in the BRCA1 gene. Statistical analysis was performed to examine allele frequency, odds ratio, and relative risk (genetic association) in a retrospective case-control study.ResultsThe data showed no association between rs386833395 and BC risk in the studied population (odds ratio = 1), whereas rs80359550 and rs180177102 polymorphisms were strongly associated with BC risk in patients (odds ratio = 0.01 for both, with p-values of 0.011 and 0.021, respectively).ConclusionsOur findings suggest no significant association between the rs386833395 polymorphism and BC risk in the Iranian Kurdish population, while rs80359550 and rs180177102 polymorphisms were strongly associated with BC. However, the study has several limitations, including its retrospective design, a relatively small sample size, and the potential lack of generalizability to other ethnic groups within Iran. Future studies involving larger cohorts and more diverse populations are needed to confirm these results.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Founder BRCA1/BRCA2/PALB2 pathogenic variants in French-Canadian breast cancer cases and controls
    Supriya Behl
    Nancy Hamel
    Manon de Ladurantaye
    Stéphanie Lepage
    Réjean Lapointe
    Anne-Marie Mes-Masson
    William D. Foulkes
    Scientific Reports, 10
  • [22] Mutations of BRCA1, BRCA2, and PALB2 Genes in Breast Tumor Tissue: Relationship with the Effectiveness of Neoadjuvant Chemotherapy and Disease Prognosis
    Tsyganov, Matvey M.
    Sorokovikova, Sofia S.
    Lutzkaya, Elizaveta A.
    Ibragimova, Marina K.
    GENES, 2023, 14 (08)
  • [23] Founder BRCA1/BRCA2/PALB2 pathogenic variants in French-Canadian breast cancer cases and controls
    Behl, Supriya
    Hamel, Nancy
    de Ladurantaye, Manon
    Lepage, Stephanie
    Lapointe, Rejean
    Mes-Masson, Anne-Marie
    Foulkes, William D.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [24] Clinicopathological significance of mutations in BRCA1, BRCA2, and PALB2 in pancreatic ductal adenocarcinoma
    Takeuchi, Shoko
    Doi, Manami
    Ikari, Naoki
    Yamamoto, Masakazu
    Furukawa, Toru
    CANCER SCIENCE, 2018, 109 : 755 - 755
  • [25] PALB2 Physically and Functionally Connects BRCA1 and BRCA2 into a Pathway of Homologous Recombination
    Zhang, F.
    Fan, Q.
    Ren, K.
    Andreassen, P. R.
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2009, 50 (07) : 554 - 554
  • [26] BRCA1 and BRCA2 in breast cancer
    Yang, XH
    Lippman, ME
    BREAST CANCER RESEARCH AND TREATMENT, 1999, 54 (01) : 1 - 10
  • [27] BRCA1 and BRCA2 in breast cancer
    Lee, WH
    Boyer, TG
    LANCET, 2001, : S5 - S5
  • [28] BRCA1 and BRCA2 in breast cancer
    Xiaohong Yang
    Marc E. Lippman
    Breast Cancer Research and Treatment, 1999, 54 : 1 - 10
  • [29] PALB2 connects BRCA1 and BRCA2 in the G2/M checkpoint response
    Srilatha Simhadri
    Gabriele Vincelli
    Yanying Huo
    Sarah Misenko
    Tzeh Keong Foo
    Johanna Ahlskog
    Claus S. Sørensen
    Gregory G. Oakley
    Shridar Ganesan
    Samuel F. Bunting
    Bing Xia
    Oncogene, 2019, 38 : 1585 - 1596
  • [30] BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study
    Zhen, David B.
    Rabe, Kari G.
    Gallinger, Steven
    Syngal, Sapna
    Schwartz, Ann G.
    Goggins, Michael G.
    Hruban, Ralph H.
    Cote, Michele L.
    McWilliams, Robert R.
    Roberts, Nicholas J.
    Cannon-Albright, Lisa A.
    Li, Donghui
    Moyes, Kelsey
    Wenstrup, Richard J.
    Hartman, Anne-Renee
    Seminara, Daniela
    Klein, Alison P.
    Petersen, Gloria M.
    GENETICS IN MEDICINE, 2015, 17 (07) : 569 - 577